
TSE:JWEL
This summary was created by AI, based on 2 opinions in the last 12 months.
Jamieson Wellness (JWEL-T) is currently viewed positively by market experts, with several indicators pointing towards a strong future. The company has successfully navigated recent market conditions and remains resilient, particularly with its core business performing well. Experts highlight the potential for unsolicited takeout offers, increased demand in international markets like China, and consistent dividend growth of 14% over the past five years. Additionally, Jamieson's strategic acquisitions, including a California-based company, have insulated it from tariff impacts, further bolstering its market position. Analysts set a bullish price target of $42.43, suggesting there could be further upside from current valuations.
(A Top Pick July 20/17, Up 56%) He looks for companies that dominate their market. This is the number one consumer healthcare brand. More than the next 5 largest competitors combined. It was a show-me story at the time. It needs to penetrate other geographical markets like China for continued growth. It is fairly valued at this price.
It is the most prominent name in wellness and vitamins. This company is becoming globally entrenched, but it is very Canadian. It will carry on growing. It has had great numbers. They are at the low end of the price range as holistic people would be willing to pay three times more for the pills. He thinks it has growth potential. (Analysts’ target: $22.25).
It is the MacDonald’s of the vitamin business. It is the number one Canadian consumer health brand. They have more market share than their 5 biggest peers combined. They have exposure in China. He thinks it will be a success-IPO story like DOL-T. It is now going to be a show-me story as they grow their top line.
He likes the trend towards health and wellness through supplements and protein shakes. The company has been given a license to sell their branded product in China. His fund will continue to hold this stock.